Functional precision oncology using patient-derived assays: bridging genotype and phenotype

AWJ van Renterghem, J van de Haar… - Nature Reviews Clinical …, 2023 - nature.com
Genomics-based precision medicine has revolutionized oncology but also has inherent
limitations. Functional precision oncology is emerging as a complementary approach that …

Bioengineering trends in female reproduction: a systematic review

E Frances-Herrero, R Lopez, M Hellström… - Human …, 2022 - academic.oup.com
BACKGROUND To provide the optimal milieu for implantation and fetal development, the
female reproductive system must orchestrate uterine dynamics with the appropriate …

Using patient-derived organoids to predict locally advanced or metastatic lung cancer tumor response: a real-world study

HM Wang, CY Zhang, KC Peng, ZX Chen, JW Su… - Cell Reports …, 2023 - cell.com
Predicting the clinical response to chemotherapeutic or targeted treatment in patients with
locally advanced or metastatic lung cancer requires an accurate and affordable tool. Tumor …

Next‐Generation Preclinical Functional Testing Models in Cancer Precision Medicine: CTC‐Derived Organoids

L Huang, Y Xu, N Wang, K Yi, X Xi, H Si… - Small …, 2024 - Wiley Online Library
Basic and clinical cancer research requires tumor models that consistently recapitulate the
characteristics of prima tumors. As ex vivo 3D cultures of patient tumor cells, patient‐derived …

Organoids: opportunities and challenges of cancer therapy

X Jiang, L Oyang, Q Peng, Q Liu, X Xu, N Wu… - Frontiers in Cell and …, 2023 - frontiersin.org
Organoids are a class of multicellular structures with the capability of self-organizing and the
characteristic of original tissues, they are generated from stem cells in 3D culture in vitro …

Patient-derived organoids and high grade serous ovarian cancer: from disease modeling to personalized medicine

C Nero, G Vizzielli, D Lorusso, E Cesari… - Journal of Experimental …, 2021 - Springer
Background High grade serous ovarian cancer (HGSOC) is among the deadliest human
cancers and its prognosis remains extremely poor. Tumor heterogeneity and rapid …

Molecular and functional landscape of malignant serous effusions for precision oncology

R Wegmann, L Bankel, Y Festl, K Lau, S Lee… - Nature …, 2024 - nature.com
Personalized treatment for patients with advanced solid tumors critically depends on the
deep characterization of tumor cells from patient biopsies. Here, we comprehensively …

The high-grade serous ovarian cancer metastasis and chemoresistance in 3D models

V Tadić, W Zhang, A Brozovic - … et Biophysica Acta (BBA)-Reviews on …, 2024 - Elsevier
High-grade serous ovarian cancer (HGSOC) is the most frequent and aggressive type of
epithelial ovarian cancer, with high recurrence rate and chemoresistance being the main …

Head and neck cancer patient-derived tumouroid cultures: Opportunities and challenges

BWMTJ Basnayake, P Leo, S Rao, S Vasani… - British Journal of …, 2023 - nature.com
Head and neck cancers (HNC) are the seventh most prevalent cancer type globally. Despite
their common categorisation, HNCs are a heterogeneous group of malignancies arising in …

Successful patient-derived organoid culture of gynecologic cancers for disease modeling and drug sensitivity testing

J Bi, AM Newtson, Y Zhang, EJ Devor, MI Samuelson… - Cancers, 2021 - mdpi.com
Simple Summary In the conventional treatment of gynecologic malignancies, most patients
receive similar 'one-size-fits-all'treatment. However, it is increasingly clear that standard …